Lannett’s primidone
Executive Summary
Philadelphia-based generic firm supplemental ANDA for anticonvulsant primidone, an AB-rated equivalent of Wyeth-Ayerst's Mysoline, approved Nov. 9. Approval is second for Lannett since it suspended operations in August 1991 to upgrade facilities and establish inventory and quality control procedures. Primidone will be available in 250 mg capsules for $310 per 1,000.